In this context, lovastatin, a β-Hydroxy β-methylglutaryl-coenzyme A reductase (HMGCR) inhibitor, was shown to induce apoptosis in several BRAF-mutated and metastases-derived melanoma cell lines [16]. Here, BRAF is linked to melanoma.